CDW Stockholders Approve Written Consent, Elect Directors at Annual Meeting
Summary
CDW Corp's stockholders approved an amendment to permit action by written consent and elected directors at the annual meeting, while rejecting a proposal for an independent board chair.
Key Events
-
Stockholder Action by Written Consent Approved
Stockholders approved an amendment to the Certificate of Incorporation to permit action by written consent, which became effective on May 22, 2026. This enhances shareholder power to act outside of annual meetings.
-
Board of Directors Elected
All nine nominated directors were elected to the Board of Directors for terms expiring at the Company's 2027 Annual Meeting of Stockholders.
-
Executive Compensation Approved
Stockholders approved, on an advisory basis, the compensation of the Company's named executive officers.
-
Independent Board Chair Proposal Rejected
A stockholder proposal regarding independent board chair requirements was not approved by the stockholders.
Analysis
This 8-K reports the definitive outcomes of several key proposals from CDW's 2026 Annual Meeting. The approval of an amendment to permit stockholder action by written consent is a significant corporate governance change, empowering shareholders to act outside of formal meetings. This finalizes a proposal previously outlined in proxy statements. Additionally, stockholders elected all nominated directors and approved executive compensation, while rejecting a proposal for an independent board chair, indicating the company's current leadership structure will remain.
At the time of this filing, CDW was trading at $108.59 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $13.9B. The 52-week trading range was $97.12 to $186.70. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.